Transcription of Designated: January 10, 2018
{{id}} {{{paragraph}}}
Example: bachelor of science
Designated: January 10, 2018
Paper 15571-272-7822 Entered: June 27, 2014 UNITED STATES PATENT AND TRADEMARK OFFICE _____ BEFORE THE PATENT TRIAL AND APPEAL BOARD _____ AMNEAL PHARMACEUTICALS, LLC, Petitioner, PHARMACEUTICALS INC., Patent Owner. _____ Case IPR2014-00360 Patent 8,329,216 B2_____ Before TONI R. SCHEINER, FRANCISCO C. PRATS, and JACQUELINE WRIGHT BONILLA,Administrative Patent Judges. BONILLA,Administrative Patent Judge. DECISION Service Under 35 315(b)Designated: January 10, 2018 IPR2014-00360 Patent 8,329,216 B2 2 INTRODUCTION Petitioner Amneal Pharmaceuticals, LLC, filed a petition (Paper 1) requesting inter partes review of Patent No. 8,329,216 ( the 216 patent ) on January 16, 2014. Patent Owner Endo Pharmaceuticals Inc.
IPR2014-00360 Patent 8,329,216 B2 3 I. BACKGROUND We consider arguments raised in Patent Owner’s Preliminary Response challenging whether Petitioner timely filed its Petition for inter partes review of the ’216 patent. Prelim.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: